Biomarker exploration in patients undergoing boron neutron capture therapy (BNCT).
Not Applicable
Recruiting
- Conditions
- Cancer
- Registration Number
- JPRN-UMIN000050486
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients for whom the necessary samples for analysis could not be obtained.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method metabolome analysis, proteome analysis, comprehensive analysis of tumor gene aberrations and gene expression aberrations, comprehensive gene expression analysis of tumor-infiltrating immune cells, protein expression analysis of tumor-infiltrating immune cells, LAT-1 expression analysis
- Secondary Outcome Measures
Name Time Method Correlations between clinical information and pharmacokinetics and the primary endpoints will be examined.